David Drutz, Director at Altimmune, Inc. (ALT), bought 10,000 shares at $2.15 ($22K) on 2017-08-22, disclosed to the SEC on 2017-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 5,000 | $11K | 48.6% |
| 2 | $2.27 | 5,000 | $11K | 51.4% |
| Total | $2.21 avg | 10,000 | $22K | 100% |
| Filing → |
| ALT | BUY | 2023-03-27 | $38K | — | Filing → |
| ALT | BUY | 2022-06-16 | $8K | — | Filing → |
| ALT | BUY | 2022-05-25 | $5K | — | Filing → |